RENOVORX, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
RENOVORX, INC. (RNXT) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $9.48 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $9.48M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $12.36M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $7.02M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $10.04M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2026-06-30 | $9.48M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $12.36M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $7.02M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $10.04M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $12.31M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $14.58M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $7.15M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $9.56M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $11.74M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $4.39M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $1.17M 10-K · filed 2026-03-30 |
| 2023-09-30 | $3.23M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $5.95M 10-Q · filed 2024-08-13 |
| 2023-03-31 | $3.72M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $4.39M 10-K · filed 2025-04-01 |
| 2022-09-30 | $3.09M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $2.77M 10-Q · filed 2023-08-16 |
| 2022-03-31 | $13.12M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $15.19M 10-K · filed 2024-04-01 |
| 2021-09-30 | $17.73M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $1.56M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $837.00K 10-Q · filed 2022-05-13 |
| 2020-12-31 | $1.79M 10-K · filed 2023-03-31 |
| 2020-09-30 | $2.31M 10-Q · filed 2021-11-15 |
| 2019-12-31 | $2.12M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |